ATAGI Statement, Response to NSW COVID-19 outbreak 24th July 2021
On 24 July 2021, ATAGI advised that all individuals aged 18 years and above in greater Sydney should strongly consider getting vaccinated with any available vaccine including COVID-19 Vaccine AstraZeneca. A single dose of COVID-19 Vaccine AstraZeneca reduces transmission by around half, and provides more than 70% protection against hospitalisation.
Pfizer vaccine approved for use in people aged 12 to 15 years
On 22 July 2021 the Therapeutic Goods Administration (TGA) has provisionally approved the use of the Pfizer COVID-19 vaccine (COMIRNATY) in individuals 12 years and older (previously 16 years and older). Further details of the data supporting TGA approval are included in the Product Information.
This age group is not yet eligible in the COVID-19 vaccination program to access the Pfizer vaccine – see current eligibility criteria.
Advice for people who have received a first dose of a COVID-19 vaccine overseas
People returning to Australia from overseas who received a first dose of a COVID-19 vaccine that is not available in Australia can be offered an alternative vaccine brand to complete the primary vaccination course.
The recommended interval for administration of a second vaccine dose is 4 to 12 weeks after the first dose. A longer interval is acceptable if the second dose cannot be administered during this time window.
Advice for people with a contraindication to a second dose of COVID-19 vaccine
If an individual has a contraindication following a first dose of a COVID-19 vaccine, an alternative brand should be considered for the second dose. If the individual received either AstraZeneca, or Pfizer vaccine as their first dose, the recommended interval for administration of a second dose is 4 to 12 weeks after the first dose. A longer interval is acceptable if the second dose cannot be administered during this time window.
A serious adverse event following immunisation is an event that results in death, is life threatening, requires hospitalisation, results in persistent or significant disability or incapacity, results in a congenital anomaly/birth defect, is an unexpected reaction for that vaccine.
Prioritisation of individuals aged 70 and over
There are still high numbers of people aged 70 and above who have not received their first COVID-19 vaccine. Prioritisation for COVID-19 vaccines for individuals aged 70 and over is critical noting the number of COVID-19 outbreaks emerging across the country.
Practices are encouraged to reach out to patients not already booked in directly to support this group to get a COVID-19 vaccine appointment as soon as possible.
Mass vaccination hubs for aged and disability care workers
The Sonic Healthcare have opened a new mass vaccination clinic in the Sydney CBD. These centres specially cater to providing Pfizer COVID-19 vaccinations for Aged and Disability Care workers eligible under Phases 1a and 1b of the national vaccination roll-out program. To book, visit Sonic Health website
Aged care worker priority access through GPs and CVCs
Primary care vaccination clinics, including general practices and Commonwealth vaccination clinics (CVCs), are expected to prioritise aged care workers and make a vaccination appointment within 14 days of a request to be vaccinated. From 1 August appointments should be made within 7 days.
RACF provider-run vaccination clinics
The Government is strongly encouraging residential aged care providers to consider conducting on-site vaccination clinics. The Request for Tender (RFT) process enabling providers to vaccinate their workforce is open until 30 July 2021.
CESPHN webinar recording: Fighting the COVID-19 Delta variant
This webinar, presented by Associate Professor Nicholas Wood, Associate Director, Clinical Research and Services, NCIRS Senior Staff Specialist discusses COVID-19 vaccine risks and benefits, vaccine effectiveness, emerging data around myocarditis, and current data around mixing COVID-19 vaccines. Local GPs and RNs also share practical tips and insights on how they run their vaccination clinics.
COVID-19 live stream update for GPs
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout. Get involved by submitting questions and comments!
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…